Petrichor Names Paul Sekhri as Operating Partner [Yahoo! Finance]
vTv Therapeutics Inc. - Class A (VTVT)
Last vtv therapeutics inc. - class a earnings: 7/31 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vtvtherapeutics.com
Company Research
Source: Yahoo! Finance
NEW YORK April 1, 2026 /PRNewswire/ -- Petrichor, a leading healthcare and life sciences growth investor, today announced the appointment of Paul J. Sekhri as Operating Partner. Petrichor Logo Mr. Sekhri is a highly accomplished executive with over 35 years of leadership experience across the global life sciences industry. His career spans senior operating roles in multinational pharmaceutical companies, venture-backed biotech firms, and top-tier venture capital and private equity organizations. "We are incredibly fortunate to welcome Paul to the Petrichor family," said Tadd Wessel, Petrichor Founder and Managing Partner. "We have known Paul for years, and we admire his skills as a leader of life sciences companies, both as CEO and as Chairman of the Board. His deep experience and distinguished track record across biotech and big pharma further strengthen our ability to identify and support emerging and leading healthcare innovators in their vitally important work." Mr. Sekhr
Show less
Read more
Impact Snapshot
Event Time:
VTVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTVT alerts
High impacting vTv Therapeutics Inc. - Class A news events
Weekly update
A roundup of the hottest topics
VTVT
News
- vTv Therapeutics (VTVT) had its "sell (d-)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- vTv Therapeutics to Participate in the 38th Annual ROTH Conference [Yahoo! Finance]Yahoo! Finance
- vTv Therapeutics to Participate in the 38th Annual ROTH ConferenceGlobeNewswire
- vTv Therapeutics (VTVT) was upgraded by Evercore Inc to "strong-buy".MarketBeat
- vTv Therapeutics (VTVT) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=VTVT&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "sell" tMarketBeat
VTVT
Earnings
- 5/15/25 - Miss
VTVT
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/10/26 - Form 8-K
- 3/10/26 - Form 8-K
- VTVT's page on the SEC website